PUBLIC RELEASE DATE: 30-Jun-2014 Contact: Kathryn Ruehle kruehle@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, June 30, 2014St. John's wort is the most frequently used complementary and alternative medicine (CAM) treatment in the U.S. for depression and similar psychiatric disorders. The many commonly prescribed medications that St. John's wort can interact withsometimes with serious consequences such as serotonin syndrome or heart diseaseare reviewed in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine website. In the article "Use of St. John's Wort in Potentially Dangerous Combinations", Scott Davis, Steven Feldman, MD, PhD, and Sarah Taylor, MD, Wake Forest Baptist Medical Center, Winston-Salem, NC, present the results of a large-scale search of a national medical database across 17 years to assess how often St. John's wort is prescribed and taken with other medications that may result in adverse reactions, such as oral contraceptives, selective serotonin reuptake inhibitors (SSRIs), blood thinners, chemotherapy medicines, digoxin, statins, immunosuppressants, or HIV medicines, for example. About the Journal The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed journal publishing observational, clinical, … Continue reading →

PUBLIC RELEASE DATE: 30-Jun-2014 Contact: Marjorie Montemayor-Quellenberg mmontemayor-quellenberg@partners.org 617-534-6383 Brigham and Women's Hospital Boston, MA A research collaboration between Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) has utilized nanomedicine technologies to develop a drug-delivery system that can precisely target and attack cancer cells in the bone, as well as increase bone strength and volume to prevent bone cancer progression. The study is published the week of June 30, 2014 in Proceedings of the National Academy of Sciences. "Bone is a favorable microenvironment for the growth of cancer cells that migrate from tumors in distant organs of the body, such as breast, prostate and blood, during disease progression," said Archana Swami, PhD, BWH Laboratory of Nanomedicine and Biomaterials, co-lead study author. "We engineered and tested a bone-targeted nanoparticle system to selectively target the bone microenvironment and release a therapeutic drug in a spatiotemporally controlled manner, leading to bone microenvironment remodeling and prevention of disease progression." "There are limited treatment options for bone cancers," added Michaela Reagan, PhD, DFCI Center for Hematologic Oncology, co-lead study author. "Our engineered targeted therapies manipulate the tumor cells in the bone and the surrounding microenvironment to effectively prevent cancer from spreading in bone … Continue reading →

The treatment could edge out joint replacement procedures to a large extent. Hyderabad, June 30: A team of doctors from a city hospital have harvested stem cells of a person using bone marrow from the pelvis area to replace some dead tissues in the hip. By doing this, they saved the patient from undergoing a hip replacement. The Apollo Health City team, headed by orthopaedic specialist Paripati Sharat Kumar, diagnosed a 39-year-old women suffering from Avascular Necrosis. Her condition would require undergoing a replacement of hips. After assessing her condition, the team has decided to go for the autologous stem cell procedure (where donor and the receiver is the same person) to save both the hip joints. The minimally invasive procedure involved taking bone marrow aspirate from the patients pelvis. Stem cells were harvested from the aspirate through a process that takes about 15 minutes. Stems cells were planted in the area of damage under fluoroscopy control following core decompression, Kumar said in a statement on Monday. He feels that the autologous stem cell treatment could edge out joint replacement procedures to a large extent in the days to come. The scope of this procedure in orthopaedics and sports medicine … Continue reading →

Los Angeles, California (PRWEB) June 30, 2014 R3 Stem Cell has expanded to Southern California, and is now offering procedures in Beverly Hills to patients. The company has partnered with Beverly Hills Orthopedic Institute to now offer three different types of stem cell procedures to patients for all types of degenerative arthritis, tendonitis and ligament injuries. For more information and patient scheduling, call (310) 438-5343. R3 Stem Cell works with medical practices nationwide to offer stem cell therapy for all types of musculoskeletal conditions. The three types of procedures offered are bone marrow derived stem cell therapy, amniotic derived stem cell therapy and platelet rich plasma therapy. Said R3 CEO Bob Maguire, Patients are now benefiting from stem cell procedures by delaying or avoiding the need for joint replacement due to the amazing pain relief and regeneration possible with the procedures. We are very excited to be expanding into Southern California to help more patients and have the opportunity to work with a highly respected physician like Dr. Raj. The R3 Stem Cell partnership with Beverly Hills Orthopedic Institute brings the stem cell therapy to patients with treatment from Dr. Raj. As a Double Board Certified orthopedic doctor and a … Continue reading →